Neuropathologic evidence that the lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 1, 1998, Pages 39-46

  Brown, D F ^a   Dababo, M A ^a   Bigio, E H ^a   Risser, R C ^a   Eagan, K P ^a   Hladik, C L ^a   White III, C L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Immunohistochemistry; Lewy body disease; Parkinson disease; Ubiquitin

Indexed keywords

UBIQUITIN;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031963846     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199801000-00006     Document Type: Article

References (37)

1. Ditter SM, Mirra SS. Neuropathplogic and clinical features of Par-kinson's disease in Alzheimer's disease patients. Neurology 1987; 37:754-60
2. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8
3. Yoshimura M. Cortical changes in the parkinsonian brain: A contribution to the delineation of "diffuse Lewy body disease." J Neurol 1983;229:17-32
4. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - A new disease? Clin Neuropathol 1984;3:185-92
5. Lewy FH. Paralysis agitans. In: Lawandowsky M, ed. Handbuch der neurologie. Berlin: Springer-Verlag, 1912:920-58
6. Lipkin LE. Cytoplasmic inclusions in ganglion cells associated with Parkinsonian states: A neurocellular change studied in 53 cases and 206 control cases. Am J Pathol 1959;35:1117-33
7. Forno LS. Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): Relationship to parkinsonism. J Am Geriatr Soc 1969;17:557-75
8. Ohama E, Ikuta F. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 1976;34:311-19
9. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-39
10. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-54
11. Dickson DW, Davies P, Mayeux R, et al. Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathol 1987;75:8-15
12. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88
13. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H. Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol 1994; 13:55-59
14. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237:197-204
15. Kosaka K, Matsushita M, Oyanagi S, Mehraein P. A clinicopathological study of the "Lewy body disease." Psychiatr Neurol Jap 1980;82:292-311
16. Sima AAF, Clark AW, Sternberger NA, Sternberger LA. Lewy body dementia without Alzheimer changes. Can J Neurol Sci 1986;13: 490-97
17. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50: 140-48
18. Guntern R, Bouras C, Hof PR. An improved staining method for senile plaques and neurofibrillary tangles in Alzheimer's disease: Quantitative comparison with other techniques [abstract]. Soc Neurosci Abstr 1989;15:1033
19. Vallet PG, Guntern R, Hof PR, et al. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 1992;83:170-78
20. Guntern R, Bouras C, Hof PR, Vallet PG. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 1992;48:8-10
21. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-44
22. Stern MB, Hurting HI. The clinical characteristics of Parkinson's disease and parkinsonian syndromes: Diagnosis and assessment. In: The comprehensive management of parkinson's disease. New York, New York: PMA Corp.; 1978:3-50
23. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991;41:1402-9
24. Kim H, Gearing M, Mirra SS. Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 1995; 45:1768-70
25. Ball MJ. The morphological basis of dementia in Parkinson's disease. Can J Neurol Sci 1984;11:180-84
26. Katzman R, Galasko D, Saitoh T, Thal LJ, Hansen L. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn 1995;28:259-65
27. Hladik CL, Dababo A, Bigio EH, White CL, III. Automated double-label immunohistochemistry using antibodies to tau and ubiquitin to distinguish neocortical Lewy bodies from globose neurofibrillary tangles in brains from demented patients [abstract]. J Neuropathol Exp Neurol 1995;54:446
28. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
29. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-88
30. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52
31. McKeith IG, Galasko D, Kosaka K, et al. Concensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24
32. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-91
33. Lloyd KG. CNS compensation to dopamine neuron loss in Parkinson's disease. Adv Exp Med Biol 1977;90:255-56
34. Byrne EJ, Lennox G, Godwin-Austen RB, et al. Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 1994; 2:283-84
35. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-22
36. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-78
37. Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol 1991;48:1147-49